Dutch Cancer Foundation (KWF) grant for Dömling
Prof. Alex Dömling, Drug Design group of GRIP, together with co-workers of the UMCG (Profs. H. Nijmans and P. Elsinga) recently was awarded a grant of approx. €840.000 by the Dutch Cancer Foundation (KWF) research and implementation programme. The project is titled: Non-invasive whole-body imaging of immune checkpoints using radiolabeled small molecules as predictive biomarker for response to therapy.
In the project, small molecules will be developed for use as PET tracers and provide proof-of-concept for their use as a predictive biomarker. The multidisciplinary team of clinicians, chemists, nuclear medicine specialists and preclinical research staff involved in this project makes us uniquely suited to develop an imaging product with near-future clinical applications.
| Last modified: | 08 June 2017 1.25 p.m. |
More news
-
03 March 2025
Six MSCA Postdoctoral Fellowships at FSE
Six European researchers will start at the Faculty of Science and Engineering (UG) with a Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowship.
-
03 March 2025
Elisabeth Wilhelm partner in consortium developing type 2 diabetes app
Dr. Elisabeth Wilhelm is partner in a consortium receiving a EUR 1.2 million ERDF-subsidy to develop an app to guide diabetes patients to a drug-free life.
-
03 March 2025
A tabletop version of a huge X-ray facility
What if your research requires a huge international facility, which is far away and has limited availability? Moniek Tromp has built a tabletop version that allows her to take a large part of the measurements on new batteries in her own lab.